Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases

European Journal of Immunology

Volumn 43, Issue 4, 2013, Pages 1109-1120

  Chang, Cynthia X L ^a,b   Tan, Anthony T ^c   Or, Ming Yan ^a   Toh, Kai Yee ^a   Lim, Pei Yiing ^a   Chia, Adeline S E ^c   Froesig, Thomas M ^d   Nadua, Karen D ^a   Oh, Hsueh Ling J ^e   Leong, Hoe Nam ^f   Hadrup, Sine R ^d   Gehring, Adam J ^c   Tan, Yee Joo ^a,e   Bertoletti, Antonio ^a,c   Grotenbreg, Gijsbert M ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^f SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

CD8+ T cell response; Conditional ligand; Epitope mapping; HLA polymorphism; Immunotechnology

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; LIGAND; TETRAMER;

ARTICLE; ASIAN; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; ETHNICITY; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC VARIABILITY; HEPATITIS B; HLA TYPING; HUMAN; MOLECULAR LIBRARY; POPULATION; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION; VIRUS INFECTION;

AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HLA ANTIGENS; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; VIRUS DISEASES;

EID: 84876427574     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201243088     Document Type: Article

References (40)

1. de Campos-Lima, P. O., Gavioli, R., Zhang, Q. J., Wallace, L. E., Dolcetti, R., Rowe, M., Rickinson, A. B. et al., HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993. 260: 98-100.
2. Tan, A. T., Loggi, E., Boni, C., Chia, A., Gehring, A. J., Sastry, K. S., Goh, V. et al., Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J. Virol. 2008. 82: 10986-10997.
3. Gaudieri, S., Rauch, A., Park, L. P., Freitas, E., Herrmann, S., Jeffrey, G., Cheng, W. et al., Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J. Virol. 2006. 80: 11094-11104.
4. Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S. and Mallal, S. A., Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002. 296: 1439-1443.
5. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. et al., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 94-96.
6. Davis, M. M., Altman, J. D. and Newell, E. W., Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis. Nat. Rev. Immunol. 2011. 11: 551-558.
7. Wooldridge, L., Lissina, A., Cole, D. K., van den Berg, H. A., Price, D. A. and Sewell, A. K., Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology 2009. 126: 147-164.
8. Chang, C. X., Dai, L., Tan, Z. W., Choo, J. A., Bertoletti, A. and Grotenbreg, G. M., Sources of diversity in T cell epitope discovery. Front Biosci. 2011. 17: 3014-3035.
9. Liu, J., Zhang, S., Tan, S., Zheng, B. and Gao, G. F., Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development. Exp. Biol. Med. (Maywood) 2011. 236: 253-267.
10. Hadrup, S. R., Bakker, A. H., Shu, C. J., Andersen, R. S., van Veluw, J., Hombrink, P., Castermans, E. et al., Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat. Methods 2009. 6: 520-526.
11. Newell, E. W., Klein, L. O., Yu, W. and Davis, M. M., Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat. Methods 2009. 6: 497-499.
12. Toebes, M., Coccoris, M., Bins, A., Rodenko, B., Gomez, R., Nieuwkoop, N. J., van de Kasteele, W. et al., Design and use of conditional MHC class I ligands. Nat. Med. 2006. 12: 246-251.
13. Bakker, A. H., Hoppes, R., Linnemann, C., Toebes, M., Rodenko, B., Berkers, C. R., Hadrup, S. R. et al., Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc. Natl. Acad. Sci. USA 2008. 105: 3825-3830.
14. Grotenbreg, G. M., Roan, N. R., Guillen, E., Meijers, R., Wang, J. H., Bell, G. W., Starnbach, M. N. et al., Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc. Natl. Acad. Sci. USA 2008. 105: 3831-3836.
15. Gredmark-Russ, S., Cheung, E. J., Isaacson, M. K., Ploegh, H. L. and Grotenbreg, G. M., The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J. Virol. 2008. 82: 12205-12212.
16. Frickel, E. M., Sahoo, N., Hopp, J., Gubbels, M. J., Craver, M. P., Knoll, L. J., Ploegh, H. L. et al., Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J. Infect. Dis. 2008. 198: 1625-1633.
17. Brackenridge, S., Evans, E. J., Toebes, M., Goonetilleke, N., Liu, M. K., di Gleria, K., Schumacher, T. N. et al., An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J. Virol. 2011. 85: 5415-5422.
18. Hombrink, P., Hadrup, S. R., Bakker, A., Kester, M. G., Falkenburg, J. H., von dem Borne, P. A., Schumacher, T. N. et al., High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations. PLoS One 2011. 6: e22523.
19. Unger, W. W., Velthuis, J., Abreu, J. R., Laban, S., Quinten, E., Kester, M. G., Reker-Hadrup, S. et al., Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers. J. Autoimmun. 2011. 37: 151-159.
20. Broen, K., Greupink-Draaisma, A., Woestenenk, R., Schaap, N., Brickner, A. G. and Dolstra, H., Concurrent detection of circulating minor histocompatibility antigen-specific CD8+ T cells in SCT recipients by combinatorial encoding MHC multimers. PLoS One 2011. 6: e21266.
21. Sidney, J., Peters, B., Frahm, N., Brander, C. and Sette, A., HLA class I supertypes: a revised and updated classification. BMC Immunol. 2008. 9: 1.
22. Hadrup, S. R., Toebes, M., Rodenko, B., Bakker, A. H., Egan, D. A., Ovaa, H. and Schumacher, T. N., High-throughput T-cell epitope discovery through MHC peptide exchange. Methods Mol. Biol. 2009. 524: 383-405.
23. Chew, S. L., Or, M. Y., Chang, C. X., Gehring, A. J., Bertoletti, A. and Grotenbreg, G. M., Stability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads. J. Biol. Chem. 2011. 286: 28466-28475.
24. Gehring, A. J., Xue, S. A., Ho, Z. Z., Teoh, D., Ruedl, C., Chia, A., Koh, S. et al., Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J. Hepatol. 2011. 55: 103-110.
25. Oh, H. L., Chia, A., Chang, C. X., Leong, H. N., Ling, K. L., Grotenbreg, G. M., Gehring, A. J. et al., Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope. J. Virol. 2011. 85: 10464-10471.
26. Lafuente, E. M. and Reche, P. A., Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr. Pharm. Des. 2009. 15: 3209-3220.
27. Lundegaard, C., Lund, O., Buus, S. and Nielsen, M., Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 2010. 130: 309-318.
28. Hoof, I., Peters, B., Sidney, J., Pedersen, L. E., Sette, A., Lund, O., Buus, S. et al., NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009. 61: 1-13.
29. Nielsen, M., Lundegaard, C., Blicher, T., Lamberth, K., Harndahl, M., Justesen, S., Roder, G. et al., NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2007. 2: e796.
30. Zhang, L., Udaka, K., Mamitsuka, H. and Zhu, S., Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools. Brief Bioinform. 2011. 13: 350-364.
31. Lehmann, P. V. and Zhang, W., Unique strengths of ELISPOT for T cell diagnostics. Methods Mol. Biol. 2012. 792: 3-23.
32. Anthony, D. D. and Lehmann, P. V., T-cell epitope mapping using the ELISPOT approach. Methods 2003. 29: 260-269.
33. Bendall, S. C., Simonds, E. F., Qiu, P., Amir el, A. D., Krutzik, P. O., Finck, R., Bruggner, R. V. et al., Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011. 332: 687-696.
34. Newell, E. W., Sigal, N., Bendall, S. C., Nolan, G. P. and Davis, M. M., Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8(+) T cell phenotypes. Immunity 2012. 36: 142-152.
35. Rosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E. et al., Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 2011. 17: 4550-4557.
36. Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E. et al., Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006. 314: 126-129.
37. Rosenberg, S. A., Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know. Nat. Rev. Clin. Oncol. 2011. 8: 577-585.
38. Butler, M. O., Friedlander, P., Milstein, M. I., Mooney, M. M., Metzler, G., Murray, A. P., Tanaka, M. et al., Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells. Sci. Transl. Med. 2011. 3: 80ra34.
39. Andersen, R. S., Kvistborg, P., Frosig, T. M., Pedersen, N. W., Lyngaa, R., Bakker, A. H., Shu, C. J. et al., Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers. Nat. Protoc. 2012. 7: 891-902.
40. Andersen, M. H., Gehl, J., Reker, S., Geertsen, P., Becker, J. C. and Thor Stratem, P., Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil? J. Clin. Oncol. 2005. 23: 5265-5267; author reply 5267-5268.